{
    "organizations": [],
    "uuid": "381998225a98ab6ab3a8bc0d84e6d5753443731f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/fresenius-care-outlook/fresenius-medical-cuts-2018-sales-target-after-drug-dosage-shift-idUSASO0003N4",
    "ord_in_thread": 0,
    "title": "Fresenius Medical cuts 2018 sales target after drug dosage shift",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BERLIN, April 22 (Reuters) - German dialysis specialist Fresenius Medical Care cut its 2018 sales target after a reduction in the dosing of calcimimetic drugs in the United States.\nThe company said on Sunday it now expects sales to rise by 5-7 percent at constant currency, compared with a previous forecast for a rise of around 8 percent.\nIt confirmed a target for net income to rise by 13-15 percent at constant currency.\nReporting by Victoria Bryan, editing by David Evans\n ",
    "published": "2018-04-22T23:09:00.000+03:00",
    "crawled": "2018-04-23T22:21:41.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "berlin",
        "april",
        "reuters",
        "german",
        "dialysis",
        "specialist",
        "fresenius",
        "medical",
        "care",
        "cut",
        "sale",
        "target",
        "reduction",
        "dosing",
        "calcimimetic",
        "drug",
        "united",
        "state",
        "company",
        "said",
        "sunday",
        "expects",
        "sale",
        "rise",
        "percent",
        "constant",
        "currency",
        "compared",
        "previous",
        "forecast",
        "rise",
        "around",
        "percent",
        "confirmed",
        "target",
        "net",
        "income",
        "rise",
        "percent",
        "constant",
        "currency",
        "reporting",
        "victoria",
        "bryan",
        "editing",
        "david",
        "evans"
    ]
}